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Edited by Peter BrzezinskiAbstract Blue ﬂuorescent protein from the calcium-sensitive
photoprotein aequorin (BFP-aq) was prepared and determined to
be a heat resistant enzyme, catalyzing the luminescent oxidation
of coelenterazine (luciferin) with molecular oxygen as a general
luciferase. After treatment with excess ethylenediaminetetraace-
tic acid to remove Ca2þ from BFP-aq, the blue ﬂuorescence
shifted to a greenish ﬂuorescence. This greenish ﬂuorescent
protein (gFP-aq) was identiﬁed as a non-covalent complex of
apoaequorin with coelenteramide (oxyluciferin) in a molar ratio
of 1:1. By incubation with coelenterazine in the absence of
reducing reagents, gFP-aq was converted to aequorin at 25 C.
BFP-aq and gFP-aq possessing both ﬂuorescence and lumines-
cence activities may work as novel reporter proteins.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The photoprotein aequorin isolated from the bioluminescent
jellyﬁsh, Aequorea aequorea (synonyms Aequorea victoria or
Aequorea forskalea), emits blue light by an intramolecular re-
action when the protein binds Ca2þ [1] and decomposes into
apoaequorin (Ca2þ), coelenteramide and CO2 [2]:
Aequorin                   Apoaequorin (Ca2+) + Coelenteramide + CO2 + Light
 +Ca2+
Coelenterazine/O2 Ca2+/EDTA
The primary structure of apoaequorin has been determined
by cDNA cloning [3] and consists of 189 amino acid residues.
Recently, the crystal structure of aequorin was solved and re-
vealed that three functional EF-hand structures and three free* Corresponding address. Fax: +81-45-786-5512.
E-mail address: sinouye@chisso.co.jp (S. Inouye).
Abbreviations: BFP-aq, blue ﬂuorescent protein from aequorin; gFP-
aq, greenish ﬂuorescent protein from aequorin; CTZ, coelenterazine;
CTM, coelenteramide; CD, circular dichroism; EDTA, ethylenedi-
aminetetraacetic acid; DTT, dithiothreitol; MALDI-TOF-MS, matrix-
assisted laser desorption/ionization time-of-ﬂight mass spectrometry;
rlu, relative light units; TLC, thin-layer chromatography; SDS–PAGE,
sodium dodecylsulfate–polyacrylamide gel electrophoresis
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doi:10.1016/j.febslet.2004.09.078cysteine residues are present in the molecule. Further, the
peroxide structure of coelenterazine at the C2 position was
conﬁrmed [4]. The cDNA encoding apoaequorin has been ex-
pressed in various eukaryotic and prokaryotic cells [5–7].
Apoaequorin expressed by these cells can be regenerated to
aequorin in the presence of ethylenediaminetetraacetic acid
(EDTA), a reducing reagent (i.e., 2-mercaptoethanol or dithi-
othreitol (DTT)), molecular oxygen (O2) and coelenterazine
[5,8]. Alternatively, semi-synthetic aequorins, in which the
coelenterazine moiety has been replaced with various analogs
of coelenterazine, have been produced and characterized [9–11].
Coelenterazine, a small organic compound (Mw ¼ 423), is
used as a luciferin for various luciferase reactions including
Renilla luciferase [12], Oplophorus luciferase [13], Periphylla
luciferase [14] and Gaussia luciferase [15] (Fig. 1) and also
serves as the chromogenic compound of aequorin [4]. Al-
though aequorin is not classiﬁed as a luciferase, the regener-
ation process combining with apoaequorin, coelenterazine and
molecular oxygen to give aequorin is similar to the formation
of an enzyme–substrate complex. Thus, aequorin (the non-
covalent complex of apoaequorin with the hydroperoxide of
coelenterazine) may be taken as comparable to an enzyme–
substrate complex, as proposed by Hastings and Gibson in
1963 [16]. The product from the Ca2þ-triggered reaction of
aequorin was named ‘‘blue ﬂuorescent protein’’ (BFP-aq in
this paper) [17] and the ﬂuorescence spectrum was identical to
that of the bioluminescence of aequorin [17–19]. BFP-aq, as a
complex of Ca2þ-bound apoaequorin with coelenteramide,
would then correspond to an enzyme–product complex.
In 1921, Harvey reported that squeezed extracts from the
margin of the umbrella of Aequorea glowed blue for some
hours, in one case for nine hours [20]. Shimomura and Johnson
indicated that, after the Ca2þ-triggered luminescent reaction of
native aequorin, the reaction mixture produced the continuous
luminescence by incubation with coelenterazine [8]. Later in
1995, the conversion eﬃciency of BFP-aq from recombinant
aequorin resulting from addition of excess Ca2þ was estimated
to be 33% [21] and Shimomura proposed that the complex of
Ca2þ-bound apoaequorin with coelenteramide might act as an
enzyme, catalyzing the luminescent oxidation of coelenterazine
[21]. However, the complex of Ca2þ-bound apoaequorin with
coelenteramide or of apoaequorin with coelenteramide was not
puriﬁed to homogeneity and not characterized in detail.
In this paper, the blue ﬂuorescent protein (BFP-aq: a com-
plex of Ca2þ-bound apoaequorin with coelenteramide) and theblished by Elsevier B.V. All rights reserved.
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Fig. 1. Bioluminescence reaction of coelenterazine catalyzed by luciferase.
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free apoaequorin and coelenteramide), both derived from ae-
quorin, were prepared eﬃciently using slow interacting con-
ditions with Ca2þ and characterized. We have shown that
BFP-aq is a heat resistant protein that catalyzes the lumines-
cence oxidation of coelenterazine and that gFP-aq can be re-
generated to aequorin without reducing reagents.2. Materials and methods
2.1. Materials
EDTA disodium salt, CaCl2  2 H2O, ðÞ-DTT, ())-quinine sulfate
dihydrate and 0.1 N H2SO4 (analytical grade) were obtained from
Wako Pure Chemicals (Osaka, Japan). Coelenterazine was chemically
synthesized. Coelenteramide as an authentic compound was kindly
provided by Dr. O. Shimomura (Photoprotein Lab., Woods Hole) and
coelenterazine analogs were kindly given by Dr. K. Teranishi (Mie
Univ., Japan).
2.2. Preparation of recombinant aequorin
Recombinant apoaequorin and aequorin were prepared as previ-
ously reported [22,23]. Brieﬂy, apoaequorin was expressed in the
periplasmic space of Escherichia coli strain WA802 carrying piP-HE
expression vector, followed by regeneration into aequorin and puriﬁ-
cation [23]. The purity of recombinant apoaequorin in aequorin on
sodium dodecylsulfate–polyacrylamide gel electrophoresis (SDS–
PAGE) analysis was over 95% [24].
2.3. Preparation of BFP-aq and gFP-aq from aequorin
A solution of puriﬁed recombinant aequorin (8 mg) in 10 mM Tris–
HCl, pH 7.6, containing 2 mM EDTA and 1.2 M (NH4)2SO4 was
concentrated to 0.1 ml using a centrifugal concentrator, Vivaspin 2
(10 000 MWCO; Sartorius AG, Germany), at 5000 g for 1 h at 4 C.
The concentrated solution of aequorin showed an orange color with a
high viscosity. To prepare BFP-aq, 0.9 ml of 50 mM Tris–HCl, pH 7.6,
containing 5 mM CaCl2 and 2 mM DTT (Ca
2þ solution) was layered
on the aequorin solution in the centrifugal concentrator and allowed to
stand at 4 C. A blue luminescent band was observed at the interface
between the aequorin solution and the Ca2þ solution over 24 h. After
this continuous luminescence of aequorin was ﬁnished, the orange
color of aequorin had disappeared completely and the blue ﬂuores-
cence of BFP-aq could be detected under a long wave UV lamp
(kmax ¼ 366 nm). The BFP-aq solution in the centrifugal concentrator
was washed two times with 2 ml of the Ca2þ solution and concentrated
by centrifugation using the same procedure. A quantitative yield of
BFP-aq from aequorin was obtained. For preparation of gFP-aq from
BFP-aq, 2 ml of 50 mM Tris–HCl, pH 7.6, containing 10 mM EDTA
(EDTA solution) was added to 0.1 ml of the BFP-aq solution and
washed by dilution and concentration three times with 2 ml of the
EDTA solution. After removing Ca2þ ions from BFP-aq, gFP-aq
having greenish ﬂuorescence was obtained.
2.4. Preparation of Ca2þ-bound apoaequorin
The complex of Ca2þ-bound apoaequorin was prepared from reduced
apoaequorin with CaCl2. Thus, Ca
2þ-free apoaequorin was puriﬁed by
reversed-phase HPLC as previously described [22,23]. The solution of
Ca2þ-free apoaequorin (1 mg/ml) was incubated in 50 mM Tris–HCl
(pH 7.6) containing 1 mM EDTA and 10 mM DTT at 4 C. After in-
cubation for 18 h, CaCl2 was added to a ﬁnal concentration of 10 mM
and the complex of Ca2þ-bound apoaequorin for assay was obtained.2.5. Measurements of absorption and ﬂuorescence spectra
Absorption spectra of BFP-aq and gFP-aq were measured in 50 mM
Tris–HCl (pH 7.6) containing 10 mM CaCl2 or 10 mM EDTA with a
Jasco (Tokyo, Japan) V-560 spectrophotometer (band path 1.0 nm;
response, Medium; scan speed, 200 nm/min) at 22–25 C using a quartz
cuvette (10 mm light path). The ﬂuorescence spectra were measured
with a Jasco FP-777W ﬂuorescence spectrophotometer (emission and
excitation band path, 1.5 nm; response, 0.5 s; scan speed, 60 nm/min)
and were corrected according to the manufacturers instructions.
Fluorescence quantum yields were determined relative to quinine sul-
fate (quantum yield ¼ 0.55, excited at 355 nm) in 0.1 M H2SO4 as a
standard.
2.6. Measurement of bioluminescent spectra
Luminescence spectra of recombinant aequorin with Ca2þ and BFP-
aq with coelenterazine were measured on a Jasco FP-777W ﬂuores-
cence spectrophotometer (scan speed, 60 nm/min) at 22–25 C with the
excitation light source turned oﬀ.
2.7. Measurement of circular dichroism (CD) spectra
CD spectra were measured on a Jasco J-820 spectrometer at 20 C or
45 C using a quartz cuvette (2 mm light path, scan speed, 50 nm/min).
The protein solutions (0.22 mg/ml) in 10 mM MES (pH 6.6), 100 mM
KCl and 1 mM DTT were measured in the presence or absence of 1
mM CaCl2.
2.8. Identiﬁcation of coelenteramide as a prosthetic group for
ﬂuorescence in BFP-aq and gFP-aq
The BFP-aq or gFP-aq protein (0.26 mg/0.1 ml) was added to 0.9 ml
of methanol (HPLC grade) and the solution was heated at 95 C for 3
min in a heating block. After cooling on ice, the supernatant was
obtained by centrifugation at 12 000 g for 5 min at room tempera-
ture. The supernatant was analyzed by thin-layer chromatography
(TLC) employing a silica gel 60 F-254 (Merck, Germany) and ethyl
acetate/chloroform (2:1) as a solvent phase. The migration of the
coelenteramide was monitored under UV light (kmax ¼ 366 nm),
comparing with synthetic coelenteramide as an authentic compound
(Rf ¼ 0.50). The absorption and the ﬂuorescence spectra of the
methanol extract showed the absorption peaks at 278, 294 and 333 nm,
and the emission peak at 428 nm (on excitation at 335 nm), respec-
tively. The concentration of coelenteramide was determined spectro-
photometrically using the absorption coeﬃcient of 16.0 103
M1 cm1 at 335 nm.
2.9. Protein analysis
Protein concentration was determined by the dye-binding method of
Bradford [25] using a commercially available kit (Bio-Rad, Richmond,
CA) and bovine serum albumin as a standard (Pierce, Rockford, IL).
SDS–PAGE analysis was carried out under reducing conditions using
a 12% separation gel (TEFCO, Tokyo, Japan), as described by
Laemmli [24].
2.10. Mass spectrometry
Matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI-TOF-MS) was measured on a Voyager DE Pro
mass spectrometer (PerSeptive Biosystems Inc., Framingham, MA) as
previously described [26].
2.11. Regeneration of aequorin from gFP-aq
The gFP-aq solution without DTT was prepared as follows: the
gFP-aq solution (100 ll) was further washed three times with 2 ml of
the EDTA solution using a centrifugal concentrator, Vivaspin 2. For
regeneration, the reaction mixtures (100 ll) containing 20 lg of gFP-aq
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were incubated at various temperatures. The initial intensity of lumi-
nescence from regenerated aequorin was measured.
2.12. Assay for luminescence activity
The luminescence activity was measured using an Atto (Tokyo, Ja-
pan) AB2200 luminometer equipped with a Hamamatsu R4220P
photomultiplier. The initial intensity (Imax) of 1 ng of the puriﬁed re-
combinant aequorin showed 6.4 104 relative light units. (i) Assay for
aequorin: Following injection of 100 ll of 50 mM CaCl2 in 50 mM
Tris–HCl (pH 7.6) into the regenerated aequorin solution, the initial
intensity of the luminescence was recorded. (ii) Assay for luciferase
activity: The total reaction mixture (100 ll) contained coelenterazine (1
lg/ll dissolved in methanol) and 1 mM DTT in 50 mM Tris–HCl, pH
7.6. The reaction was started by addition of protein (2 lg) and the
luminescence produced was recorded for 1 min with an AB2200 lu-
minometer. The Km value for coelenterazine was determined at con-
centration from 0.1 to 25 lM of coelenterazine by the method of
Lineweaver–Burk plots.Table 1
Absorption, ﬂuorescence and bioluminescence spectra of BFP-aq and
gFP-aq
Spectroscopy BFP-aq gFP-aq
Absorbance
kmax (nm) 281, 336 282, 336
0.1% soln. at 280 nm 2.82 2.80
0.1% soln. at 335 nm 0.56 0.65
Fluorescence
kmax (nm) ex. at 335 nm 459 467
WHMF (nm)a 84 89
Quantum yield 0.079 0.073
Bioluminescence
kmax (nm) 460 459c
WHML (nm)b 84 84c
aWHMF, width at half-maximum of ﬂuorescence band.
cAequorin regenerated from gFP-aq.
bWHML, width at half-maximum of luminescence band.3. Results and discussion
3.1. Preparation of BFP-aq and gFP-aq from aequorin
To avoid confusion, the abbreviations BFP-aq and gFP-aq
have been introduced in this paper for the blue and greenish
ﬂuorescent proteins derived from aequorin. We have used
these abbreviations because the name of green ﬂuorescent
protein (GFP) from the same jellyﬁsh, A. aequorea, is familiar
and the Y66H mutant of GFP having blue ﬂuorescence has
been called BFP [27].
During the puriﬁcation of recombinant aequorin on a gram
scale, an aequorin fraction with blue-greenish ﬂuorescence was
observed accidentally. This observation suggests that the slow
interaction of Ca2þ with high concentrations of aequorin may
give a stable complex of Ca2þ-bound apoaequorin with coel-
enteramide (BFP-aq). Following the procedures described in
Section 2, aequorin has been converted to the ﬂuorescent
proteins, BFP-aq and gFP-aq (Fig. 2a). To conﬁrm the pres-
ence of coelenteramide as a chromophore, the ethanol extracts
from BFP-aq and gFP-aq were analyzed by spectral analyses
(UV spectra, ﬂuorescence emission/excitation), TLC analysis
and mass spectral analyses, in comparison with the syntheticFig. 2. BFP-aq and gFP-aq from aequorin. (a) Photograph of BFP-aq (left) a
concentrations were 2.6 mg/ml in 50 mM Tris–HCl (pH 7.6) containing 10 mM
(blue line) and gFP-aq (green line), and bioluminescence spectrum of aequ
concentration for ﬂuorescence spectra was 0.026 mg/ml in 50 mM Tris–HClcoelenteramide. The ﬂuorescence chromophore in both gFP-aq
and BFP-aq is coelenteramide. Calculations based on the ab-
sorption coeﬃcient of coelenteramide indicate that better than
95% of coelenteramide was retained in BFP-aq. After treat-
ment with excess EDTA to give gFP-aq from BFP-aq, coel-
enteramide in gFP-aq was also retained without loss. The
conversion from gFP-aq to BFP-aq was reversible without loss
of ﬂuorescent intensity. By MALDI-TOF-MS analyses of
BFP-aq and gFP-aq, the mass values gave m/z 21635.1 and
21631.5, respectively. These values were in good agreement
with that of recombinant aequorin (average mass ¼ 21632.2)
[26]. These results suggest that no modiﬁcation of amino
acid residues such as decarboxylation and dehydration occurs
in apoaequorin molecule and that coelenteramide is non-
covalently bound to apoaequorin in BFP-aq and gFP-aq.
3.2. Spectral analyses of BFP-aq and gFP-aq
The absorption spectra and ﬂuorescence emission spectra of
BFP-aq and gFP-aq, and the luminescence spectrum of ae-
quorin with Ca2þ are shown (Fig. 2b). The spectroscopic data of
BFP-aq and gFP-aq including ﬂuorescence quantum yield arend gFP-aq (right) under a long wave UV lamp (366 nm). Both protein
CaCl2 or 10 mM EDTA. (b) Fluorescence emission spectra of BFP-aq
orin with the slow interaction with Ca2þ (dashed blue line). Protein
(pH 7.6) containing 10 mM CaCl2 or 10 mM EDTA.
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Fig. 4. Luminescence catalyzed by BFP-aq (a), Ca2þ-bounded apoae-
quorin (b) and apoaequorin (c) with coelenterazine in the presence of
1 mM DTT.
Table 2
Luciferase activity of aequorin, apoaequorin, apoaequorin-Ca2þ
complex and apoaequorin-Ca2þ-coelenteramide (BFP-aq)
Conditions Relative activity (%)
Reaction mixturea >0.001
+Aequorin >0.001
+Apoaequorin 0.5
+Apoaequorin-Ca2þ complex 12.1
+Apoaequorin-Ca2þ-coelenteramide (BFP-aq) 100
aMixture (100 ll) contains 1 lg of CTZ in 50 mM Tris–HCl (pH 7.6)/1
mM DTT.
Table 3
Eﬀect of DTT and heat treatment on luciferase activity of BFP-aq
Conditions Relative activity (%)
a b
108 S. Inouye / FEBS Letters 577 (2004) 105–110summarized in Table 1. The ﬂuorescence spectrum of BFP-aq
was identical to the bioluminescent spectra of aequorin trig-
gered by Ca2þ and of BFP-aq with coelenterazine. As previ-
ously reported, the light emitter of aequorin is the amide anion
of coelenteramide [28]. The species of the light emitter in both
ﬂuorescence of BFP-aq and the luminescence of BFP-aq with
coelenterazine is presumably the amide anion of coelentera-
mide. In gFP-aq, the emitter species of coelenteramide is not
clear. The ﬂuorescence spectral change from blue to green
suggests that the binding environment of coelenteramide in the
protein was aﬀected by Ca2þ release from BFP-aq. Fluores-
cence quantum yields of BFP-aq and gFP-aq showed approx.
one-tenth the value of GFP quantum yield [27]. The spectro-
scopic properties of BFP-aq and gFP-aq are distinct from the
slow discharged ﬂuorescent protein from aequorin (emission
kmax ¼ 435 nm) [29].
3.3. Fluorescence stability of BFP-aq and gFP-aq
Aequorin, a non-ﬂuorescent protein, is heat labile and the
luminescence is inactivated completely by incubation at 95 C
for 3 min. The heat stabilities of BFP-aq and gFP-aq prepared
from aequorin were examined using ﬂuorescence measure-
ments. When BFP-aq was heated at 95 C for 3 min, the blue
ﬂuorescence of BFP-aq disappeared in a second. However, the
ﬂuorescence recovered to over 93% after incubating for a
further 20 min at 24 C (Fig. 3), showing that BFP-aq is a heat
resistant protein. Under the same conditions, the ﬂuorescence
recovery of gFP-aq reached only to 31%. On incubation at 45
C for 10 min, the ﬂuorescence of BFP-aq also disappeared but
was recovered completely on ice in a minute. The studies on
BFP-aq and gFP-aq by CD spectrometry showed that no
signiﬁcant spectral changes occurred in BFP-aq between 20
and 45 C, but that spectral changes occurred in gFP-aq. At 45
C, Ca2þ-bound apoaequorin without coelenteramide also
gave no signiﬁcant spectral changes, similar to the case of
BFP-aq. These results suggest that Ca2þ binding to the EF-0
1
2
3
4
5
6
7
400 450 500 550 600
R
el
at
iv
e 
in
te
ns
ity
Wavelength(nm)
-Heat
18min
9min
3min
1min
Fig. 3. Fluorescence recovery of BFP-aq after heat treatment. Protein
concentration was 0.26 mg/ml in 50 mM Tris–HCl (pH 7.6) containing
1 mM DTT and 1 mM CaCl2. The recovery of ﬂuorescence was
monitored from 1 to 18 min at 24 C, after heating at 95 C for 3 min.
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ture and coelenteramide in Ca2þ-bound apoaequorin retains
during heat treatment. Thus, the ﬂuorescence activity of BFP-
aq can be restored after heat treatment.
3.4. Catalytic properties of BFP-aq as a luciferase
When excess coelenterazine as a substrate was added to a
BFP-aq solution in the presence of DTT, continuous lumi-
nescence was observed over 1 h (Fig. 4a). In the absence of
DTT, the luminescence activity of BFP-aq slowly decreased
(half period ¼ 8.3 min). This phenomenon may be explained
by disulﬁde-bond formation among three free cysteine residues
in apoaequorin [3,5,8] during the oxidation of coelenterazine.
On the other hand, Ca2þ-bound apoaequorin showed weak
luminescence with coelenterazine and Ca2þ-free apoaequorin
could not give signiﬁcant luminescence (Fig. 4, lines b and c,
respectively). Thus, BFP-aq and Ca2þ-bound apoaequorin are
recognized as a luciferase. However, BFP-aq acts as a lucif-
erase more eﬃciently than Ca2þ-bound apoaequorin (Table 2).
Although coelenteramide is not an essential component to
catalyze oxidation of coelenterazine, the role of the coelen-
teramide in BFP-aq as an enzyme appears to be to maintain an
eﬃcient conformation for catalysis. For this reason, the cata-
lytic site for oxidation of coelenterazine may diﬀer from the
binding site of coelenteramide in BFP-aq and coelenteramide
in BFP-aq retains during the luminescence reaction.
After heat treatment at 95 C for 3 min in the presence of
DTT and then cooling on ice, over 93% of the luminescence
activity of BFP-aq with coelenterazine was recovered (Table
3). This result is consistent with the ﬂuorescence recovery of
BFP-aq (Fig. 3) and BFP-aq is identiﬁed as a heat resistant
protein with blue ﬂuorescence and luciferase activities. BFP-aq
and gFP-aq did not show signiﬁcant loss of their ﬂuorescence
and luciferase activities on prolonged storage, even after one
year at 4 or )80 C. As an enzyme, the Km value of BFP-aq for
coelenterazine was 13.3 lM.Substrate speciﬁcity was also ex-
amined using several coelenterazine analogs (ﬁnal concentra-
tion; 250 lM) [30]. The relative luminescence activity was as
follows: coelenterazine (100%), h-coelenterazine (175%), e-
coelenterazine (0.3%), bisdeoxycoelenterazine (0.15%), and
C6-methoxyphenylcoelenterazine (0.06%).
3.5. Regeneration of aequorin from gFP-aq without reducing
reagents
Reducing reagents such as DTT or 2-mercaptoethanol are
necessary to regenerate aequorin from apoaequorin with
coelenterazine and molecular oxygen at 4 C [5,8]. Interest-
ingly, gFP-aq possessing coelenteramide could convert to ae-quorin without a reducing reagent and at 25 C rather than
4 C (Fig. 5). Based on the luminescence activity, the conver-
sion eﬃciency to aequorin from gFP-aq was over 90% in 1 h at
25 C. After regeneration to aequorin from gFP-aq, the
greenish ﬂuorescence of gFP-aq disappeared completely. This
evidence strongly suggests that coelenteramide in gFP-aq was
replaced by the peroxide of coelenterazine in the aequorin re-
generation process (Fig. 6).
In Aequorea jellyﬁshes, high concentration of aequorin is
present in photocyte of the outer margin of the umbrella [1].
After the luminescence reaction is triggered by an increase in
free Ca2þ, aequorin in the photocyte is converted to BFP-aq.
As free calcium levels in the photocyte fall, the bound Ca2þ is
released from BFP-aq to give gFP-aq. When coelenterazine is
present in the photocyte, gFP-aq can be regenerated to ae-
quorin without reducing reagents. To account for our ﬁndings,
the schematic representations of BFP-aq and gFP-aq forma-
tion from aequorin and the regeneration to aequorin from
gFP-aq are summarized in Fig. 6. These two ﬂuorescent pro-
teins that have luciferase activity or Ca2þ-sensitive lumines-
cence activity could play useful reporter proteins in various
assay systems.
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